Top Markets
Coin of the day
Grace Therapeutics, Inc. Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCE
Rangering i aksjer #27036
Grace Therapeutics, Inc. specializes in the creation and commercialization of... Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
Aksjekurs
$2.18
Sist synkronisert: 2026-08-19
Markedsverdi
$35.55M
Endring (1 dag)
2.57%
Endring (1 år)
-33.19%
Land
US
Handel Grace Therapeutics, Inc. (GRCE)

Kategori

Aksjeprishistorikk for Grace Therapeutics, Inc. (GRCE)
Høyeste sluttskurs: $2.13 den 2026-08-01

Laveste sluttskurs: $3.24 den 2024-10-01
Aksjeprishistorikk for Grace Therapeutics, Inc. fra 2024 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -5.78%
2025 -13.39%
2024 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$758.23 6.53%
CH